speb/financial-data huggingface dataset:
Financial ratios for BLU.V — annual report dated 2025-09-30
Total revenue: 0
Operating income: -1256874.1007194247
Net income: -4388141.726618705
Capital expenditures: 935174.820143885
Operating cash flow: -914120.8633093525
Net tangible assets: 3617497.1223021587
Owner earnings: -5323316.54676259
Return on net tangible assets (%): -147.15468642515066
Buffett classification: The Gruesome
Stock price: 0.8633093525179857
Shares outstanding: 72799915
Book value: 3617497.1223021587
P/B ratio: 17.373572212275228
Market cap (USD): 62848847.482014395
Debt to equity: 0
Current ratio: 2.0924914972319453
Quick ratio: 2.0924914972319453
Free cash flow (dilution-adjusted): -2277123.021582734
Buyback yield (%): 0
Retained earnings: -5866182.01438849
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -34.74430132841559
Rule of 40 score: 0
Financial ratios for BLU.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -315099.28057553957
Net income: -376786.33093525184
Capital expenditures: 875310.7913669065
Operating cash flow: 567277.6978417267
Net tangible assets: 3617497.1223021587
Owner earnings: -1252097.1223021583
Return on net tangible assets (%): -34.61224929752893
Buffett classification: The Gruesome
Stock price: 0.8633093525179857
Shares outstanding: 72799915
Book value: 3617497.1223021587
P/B ratio: 17.373572212275228
Market cap (USD): 62848847.482014395
Debt to equity: 0
Current ratio: 2.0924914972319453
Quick ratio: 2.0924914972319453
Free cash flow (dilution-adjusted): 1083046.762589928
Buyback yield (%): 0
Retained earnings: -5866182.01438849
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.710422425298622
Rule of 40 score: 0
Financial ratios for BLU.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -277345.98540145985
Net income: -272150.3649635036
Capital expenditures: 726004.3795620437
Operating cash flow: -251011.67883211677
Net tangible assets: 3501369.343065693
Owner earnings: -998154.7445255474
Return on net tangible assets (%): -28.50755366617774
Buffett classification: The Gruesome
Stock price: 0.8029197080291971
Shares outstanding: 72799915
Book value: 3501369.343065693
P/B ratio: 16.694178982320995
Market cap (USD): 58452486.49635036
Debt to equity: 0.4179672353423353
Current ratio: 0.7569108856394183
Quick ratio: 0.7569108856394183
Interest coverage ratio: -76.96252785092162
Free cash flow (dilution-adjusted): -1073385.4014598539
Buyback yield (%): 0
Retained earnings: -6223970.0729927
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.9210719643367895
Rule of 40 score: 0
Financial ratios for BMH.AX — annual report dated 2021-06-30
Total revenue: 4122893.2330827066
Gross profit: 611144.3609022556
Operating income: -1129772.1804511277
Net income: 2493284.962406015
Capital expenditures: 9729.323308270676
Depreciation & amortization: 596504.5112781954
Net tangible assets: 3988047.3684210526
Owner earnings: 3080060.1503759394
Return on net tangible assets (%): 77.23228602461151
Buffett classification: The Gruesome
Stock price: 0.15037593984962405
P/E ratio: 9.829416939152955
Shares outstanding: 162975124
Book value: 3995308.2706766916
P/B ratio: 6.134079220740117
Market cap (USD): 24507537.44360902
Debt to equity: 0.3331341648851284
Current ratio: 0.9754890248908004
Quick ratio: 0.8752148768937655
Effective tax rate (%): 0
Interest coverage ratio: -18.685763672992262
COGS to revenue (%): 85.17680846066197
SG&A to revenue (%): 24.206229365173154
Free cash flow (dilution-adjusted): 275435.3383458647
Buyback yield (%): 0
Retained earnings: -2822670.676691729
Inventory turnover: 14.267508958000493
Receivables turnover: 2.74971880743261
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.381377691757496
FCF margin (%): 6.680632332065518
Rule of 40 score: 6.680632332065518
Financial ratios for BMH.AX — annual report dated 2022-06-30
Total revenue: 147595.86206896554
Gross profit: 28131.034482758623
Operating income: -1079268.275862069
Net income: 241920
Capital expenditures: 1868.9655172413793
Depreciation & amortization: 530686.8965517242
Net tangible assets: 3746095.1724137934
Owner earnings: 770737.9310344828
Return on net tangible assets (%): 20.574435393691783
Buffett classification: The Gruesome
Stock price: 0.1310344827586207
P/E ratio: 88.27447534665208
Shares outstanding: 162975124
Book value: 3746095.1724137934
P/B ratio: 5.70069901937429
Market cap (USD): 21355361.075862072
Debt to equity: 0.166893416188038
Current ratio: 1.2410346149306568
Quick ratio: 0.8312529531976641
Interest coverage ratio: -31.96035944041663
COGS to revenue (%): 80.9404992196772
SG&A to revenue (%): 348.1052641415982
Free cash flow (dilution-adjusted): -474828.275862069
Buyback yield (%): 0
Retained earnings: -2347150.3448275863
Inventory turnover: 0.16686831944883287
Receivables turnover: 1.0764912704281038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.8104873525315
FCF margin (%): -321.7083929088751
Revenue growth (%): -96.42009012300792
Rule of 40 score: -418.12848303188304
Financial ratios for BMH.AX — annual report dated 2023-06-30
Total revenue: 968889.4039735099
Gross profit: 187802.64900662252
Operating income: -659903.9735099338
Net income: 214688.07947019866
Capital expenditures: 0
Depreciation & amortization: 479610.59602649004
Net tangible assets: 3425185.430463576
Owner earnings: 694298.6754966887
Return on net tangible assets (%): 20.27039673010404
Buffett classification: The Gruesome
Stock price: 0.06622516556291391
P/E ratio: 50.273189811801515
Shares outstanding: 162975124
Book value: 3425185.430463576
P/B ratio: 3.151086207929962
Market cap (USD): 10793054.569536425
Debt to equity: 0.0381132746716473
Current ratio: 4.240449730771697
Quick ratio: 3.1415435496940454
Interest coverage ratio: -59.74667226286125
COGS to revenue (%): 80.61670937504059
SG&A to revenue (%): 36.30400889117943
Free cash flow (dilution-adjusted): -275400.66225165565
Buyback yield (%): 0
Retained earnings: -2039198.013245033
Inventory turnover: 2.0855940924957297
Receivables turnover: 0.9724992438820921
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.17352506313214
FCF margin (%): -28.424365167191496
Revenue growth (%): 556.4475388346506
Rule of 40 score: 528.0231736674591
Financial ratios for BMH.AX — annual report dated 2024-06-30
Total revenue: 324654
Gross profit: 67834.66666666667
Operating income: -788569.3333333334
Net income: -3118149.3333333335
Capital expenditures: 0
Depreciation & amortization: 9247.333333333334
Net tangible assets: 329870.6666666667
Owner earnings: -3108902
Return on net tangible assets (%): -942.4608836594543
Buffett classification: The Gruesome
Stock price: 0.06
Shares outstanding: 162975124
Book value: 329870.6666666666
P/B ratio: 29.643458567600238
Market cap (USD): 9778507.44
Debt to equity: 0.0509593658928954
Current ratio: 1.95462746395052
Quick ratio: 1.4986007989210406
Interest coverage ratio: -90.50837860586121
COGS to revenue (%): 79.10555031921163
SG&A to revenue (%): 93.63794480688158
Free cash flow (dilution-adjusted): 65692.66666666667
Buyback yield (%): 0
Retained earnings: -5170942
Inventory turnover: 1.6730029271004334
Receivables turnover: 0.31956419455197255
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -237.7170717198331
FCF margin (%): 20.234670346481693
Revenue growth (%): -66.49215084110092
Rule of 40 score: -46.25748049461923
Financial ratios for CB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 182.26
Shares outstanding: 387860106
Market cap (USD): 70691382919.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CB — annual report dated 2022-12-31
Total revenue: 46798913043.47826
Net income: 5702173913.043478
Capital expenditures: 0
Operating cash flow: 12236956521.73913
Depreciation & amortization: 309782608.6956522
Net tangible assets: 27334782608.695652
Owner earnings: 6011956521.73913
Return on net tangible assets (%): 21.993796723397484
Buffett classification: The Gruesome
Stock price: 211.37
P/E ratio: 14.37732202760244
Shares outstanding: 387860106
Book value: 54911956521.739136
P/B ratio: 1.4929715821137075
Market cap (USD): 81981990605.22
Debt to equity: 0.2944832637225598
Effective tax rate (%): 19.105628373168848
COGS to revenue (%): 0
SG&A to revenue (%): 7.885263035652073
Free cash flow (dilution-adjusted): 12236956521.73913
Buyback yield (%): 3.8370038964542434
Retained earnings: 52505434782.608696
Receivables turnover: 1.3846722840419372
Capitalized R&D asset: 0
FCF margin (%): 26.147950296132855
Rule of 40 score: 26.147950296132855
Financial ratios for CB — annual report dated 2023-12-31
Total revenue: 59316666666.66667
Net income: 10747619047.619047
Capital expenditures: 0
Operating cash flow: 15038095238.095238
Depreciation & amortization: 369047619.04761904
Net tangible assets: 34966666666.66667
Owner earnings: 11116666666.666666
Return on net tangible assets (%): 31.792183031458528
Buffett classification: The Gruesome
Stock price: 220.24
P/E ratio: 7.948021730856181
Shares outstanding: 387860106
Book value: 75822619047.61905
P/B ratio: 1.1266072158730371
Market cap (USD): 85422309745.44
Debt to equity: 0.22758317501687836
Effective tax rate (%): 5.364266218769683
COGS to revenue (%): 0
SG&A to revenue (%): 8.041986111668606
Free cash flow (dilution-adjusted): 15038095238.095238
Buyback yield (%): 3.360056762444677
Retained earnings: 65250000000
Receivables turnover: 1.4824313468804857
Capitalized R&D asset: 0
FCF margin (%): 25.352225745594666
Revenue growth (%): 26.747958038168257
Rule of 40 score: 52.10018378376292
Financial ratios for CB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 283.84
Shares outstanding: 387860106
Market cap (USD): 110090212487.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 272.85
Shares outstanding: 387860106
Market cap (USD): 105827629922.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CB — annual report dated 2024-12-31
Total revenue: 62233333333.33333
Net income: 10711111111.11111
Capital expenditures: 0
Operating cash flow: 17980000000
Depreciation & amortization: 358888888.8888889
Net tangible assets: 38713333333.333336
Owner earnings: 11070000000
Return on net tangible assets (%): 28.59479938005855
Buffett classification: The Gruesome
Stock price: 272.85
P/E ratio: 9.880172918038383
Shares outstanding: 387860106
Book value: 75993333333.33334
P/B ratio: 1.392590971867269
Market cap (USD): 105827629922.1
Debt to equity: 0.2219346726321022
Effective tax rate (%): 15.84460934089917
COGS to revenue (%): 0
SG&A to revenue (%): 7.820032137118373
Free cash flow (dilution-adjusted): 17980000000
Buyback yield (%): 1.8909155506781492
Retained earnings: 68401111111.11111
Receivables turnover: 1.6238548069117476
Capitalized R&D asset: 0
FCF margin (%): 28.891269416175685
Revenue growth (%): 4.917111548187676
Rule of 40 score: 33.80838096436336
Financial ratios for CB — quarterly report dated 2025-03-31
Total revenue: 15213636363.636364
Net income: 1526136363.6363637
Capital expenditures: 0
Operating cash flow: 1779545454.5454545
Depreciation & amortization: 85227272.72727273
Net tangible assets: 41492045454.545456
Owner earnings: 1611363636.3636365
Return on net tangible assets (%): 3.8835483252540195
Buffett classification: The Gruesome
Stock price: 299.16
P/E ratio: 19.007513364416383
Shares outstanding: 387860106
Book value: 80403409090.90909
P/B ratio: 1.4431257408472167
Market cap (USD): 116032229310.96
Debt to equity: 0.20504557981768073
Effective tax rate (%): 19.290865384615383
COGS to revenue (%): 0
SG&A to revenue (%): 8.06692560501942
Free cash flow (dilution-adjusted): 1779545454.5454545
Buyback yield (%): 0.6767320402186764
Retained earnings: 69264772727.27272
Receivables turnover: 0.37564534231200897
Capitalized R&D asset: 0
FCF margin (%): 11.69704212727816
Rule of 40 score: 11.69704212727816
Financial ratios for CB — quarterly report dated 2025-06-30
Total revenue: 18601250000
Net income: 3748750000
Capital expenditures: 0
Operating cash flow: 4438750000
Depreciation & amortization: 92500000
Net tangible assets: 49468750000
Owner earnings: 3841250000
Return on net tangible assets (%): 7.765003158559697
Buffett classification: The Gruesome
Stock price: 287.97
P/E ratio: 21.174309174657274
Shares outstanding: 387860106
Book value: 93058750000
P/B ratio: 1.2002318398304297
Market cap (USD): 111692074724.82
Debt to equity: 0.20116324364984486
Effective tax rate (%): 19.294940796555434
COGS to revenue (%): 0
SG&A to revenue (%): 7.559975808077414
Free cash flow (dilution-adjusted): 4438750000
Buyback yield (%): 0.8348846615101703
Retained earnings: 79901250000
Receivables turnover: 0.405808562857922
Capitalized R&D asset: 0
FCF margin (%): 23.862643639540355
Revenue growth (%): 22.26695548252166
Rule of 40 score: 46.12959912206202
Financial ratios for CB — quarterly report dated 2025-09-30
Total revenue: 20250000000
Net income: 3883750000
Capital expenditures: 0
Operating cash flow: 4548750000
Depreciation & amortization: 93750000
Net tangible assets: 52695000000
Owner earnings: 3977500000
Return on net tangible assets (%): 7.548154473858999
Buffett classification: The Gruesome
Stock price: 280.54
P/E ratio: 11.880619539526924
Shares outstanding: 387860106
Book value: 97263750000
P/B ratio: 1.118713540627829
Market cap (USD): 108810274137.24
Debt to equity: 0.2213825808690288
Effective tax rate (%): 20.210580380071903
COGS to revenue (%): 0
SG&A to revenue (%): 7.0246913580246915
Free cash flow (dilution-adjusted): 4548750000
Buyback yield (%): 1.247584394730791
Retained earnings: 83402500000
Receivables turnover: 0.4398110441439974
Capitalized R&D asset: 0
FCF margin (%): 22.462962962962962
Revenue growth (%): 8.863651636314763
Rule of 40 score: 31.326614599277725
Financial ratios for CB — annual report dated 2025-12-31
Total revenue: 75674683544.30379
Net income: 13445569620.253164
Capital expenditures: 0
Operating cash flow: 16222784810.126581
Depreciation & amortization: 381012658.2278481
Net tangible assets: 56118987341.77215
Owner earnings: 13826582278.481012
Return on net tangible assets (%): 24.637975368791448
Buffett classification: The Gruesome
Stock price: 310.23
P/E ratio: 8.949106961086445
Shares outstanding: 387860106
Book value: 100986075949.36707
P/B ratio: 1.1915092209812135
Market cap (USD): 120325840684.38
Debt to equity: 0.21593401772396248
Effective tax rate (%): 18.56792394970868
COGS to revenue (%): 0
SG&A to revenue (%): 7.533914323469884
Free cash flow (dilution-adjusted): 16222784810.126581
Buyback yield (%): 3.886072468301991
Retained earnings: 88544303797.46835
Receivables turnover: 1.6348446729380879
Capitalized R&D asset: 0
FCF margin (%): 21.43753240887878
Revenue growth (%): 21.598313140284617
Rule of 40 score: 43.0358455491634
Financial ratios for CB — quarterly report dated 2025-12-31
Total revenue: 19370886075.949368
Net income: 4063291139.240506
Capital expenditures: 0
Operating cash flow: 5139240506.329114
Depreciation & amortization: 97468354.43037975
Net tangible assets: 56118987341.77215
Owner earnings: 4160759493.670886
Return on net tangible assets (%): 7.414174222944016
Buffett classification: The Gruesome
Stock price: 310.23
P/E ratio: 9.100476512081853
Shares outstanding: 387860106
Book value: 100986075949.36707
P/B ratio: 1.1915092209812135
Market cap (USD): 120325840684.38
Debt to equity: 0.21593401772396248
Effective tax rate (%): 15.83554376657825
COGS to revenue (%): 0
SG&A to revenue (%): 7.586747696530092
Free cash flow (dilution-adjusted): 5139240506.329114
Buyback yield (%): 1.2318870764433218
Retained earnings: 88544303797.46835
Receivables turnover: 0.41848063880988845
Capitalized R&D asset: 0
FCF margin (%): 26.530745605436838
Revenue growth (%): -4.341303328645099
Rule of 40 score: 22.189442276791738
Financial ratios for CBO.AX — annual report dated 2022-06-30
Total revenue: 96287586.20689656
Gross profit: 27557241.379310347
Operating income: -9177241.379310345
Net income: -480000
Capital expenditures: 25306896.55172414
Depreciation & amortization: 12191724.137931034
Net tangible assets: 193345517.24137932
Owner earnings: -13595172.413793106
Return on net tangible assets (%): -7.0315426019525535
Buffett classification: The Gruesome
Stock price: 0.9310344827586208
Shares outstanding: 478791191
Book value: 197951034.48275864
P/B ratio: 2.2519261393448047
Market cap (USD): 445771108.862069
Debt to equity: 0.5111295374334996
Current ratio: 3.4335092621339127
Quick ratio: 0.43180171789299376
Effective tax rate (%): 127.58620689655173
Interest coverage ratio: -2.845808383233533
COGS to revenue (%): 71.38027604088326
SG&A to revenue (%): 25.140204989363756
Free cash flow (dilution-adjusted): -6431724.137931035
Buyback yield (%): 0
Retained earnings: 28631724.137931034
Inventory turnover: 0.8589664029235834
Receivables turnover: 15.170813865044009
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.5992417331924362
FCF margin (%): -6.679702328513002
Rule of 40 score: -6.679702328513002
Financial ratios for CBO.AX — annual report dated 2023-06-30
Total revenue: 111890066.22516556
Gross profit: 39894701.98675497
Operating income: -208609.27152317882
Net income: 5111920.529801324
Capital expenditures: 37068874.17218543
Depreciation & amortization: 11976821.19205298
Net tangible assets: 186166225.1655629
Owner earnings: -19980132.45033112
Return on net tangible assets (%): -10.73241530925506
Buffett classification: The Gruesome
Stock price: 0.7748344370860927
P/E ratio: 72.57231422075398
Shares outstanding: 478791191
Book value: 190588741.7218543
P/B ratio: 1.9465153062486753
Market cap (USD): 370983902.96026486
Debt to equity: 0.6861763305755259
Current ratio: 2.348265437356984
Quick ratio: 0.6486278832823906
Effective tax rate (%): 46.058700209643604
Interest coverage ratio: -0.03782874984988591
COGS to revenue (%): 64.34473288587425
SG&A to revenue (%): 24.806160256637902
Free cash flow (dilution-adjusted): -11268211.920529801
Buyback yield (%): 0
Retained earnings: 23674172.185430463
Inventory turnover: 1.0683379357108462
Receivables turnover: 11.469282465548842
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.05721135509181061
FCF margin (%): -10.070788498644601
Revenue growth (%): 16.204041074145735
Rule of 40 score: 6.133252575501134
Financial ratios for CBO.AX — annual report dated 2024-06-30
Total revenue: 151851333.33333334
Gross profit: 57379333.333333336
Operating income: 11358666.666666666
Net income: 12354666.666666666
Capital expenditures: 43194666.666666664
Depreciation & amortization: 15446666.666666666
Net tangible assets: 210044666.66666666
Owner earnings: -15393333.333333332
Return on net tangible assets (%): -7.328599948582365
Capex to operating income (%): 380.2793755135579
Buffett classification: The Gruesome
Stock price: 1.1533333333333333
P/E ratio: 44.69613427746601
Shares outstanding: 478791191
Book value: 214496666.66666666
P/B ratio: 2.5744262084259275
Market cap (USD): 552205840.2866666
Debt to equity: 0.7180002797246267
Current ratio: 2.4786953676353534
Quick ratio: 0.6650335178732512
Effective tax rate (%): 41.55418190992809
Interest coverage ratio: 1.4477015889200442
COGS to revenue (%): 62.21348072895858
SG&A to revenue (%): 18.83289357573416
Free cash flow (dilution-adjusted): -12204666.666666666
Buyback yield (%): 0
Retained earnings: 27198000
Inventory turnover: 1.3819912423565668
Receivables turnover: 11.84056765607943
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.689354179327109
FCF margin (%): -8.037246956453021
Revenue growth (%): 35.71475865225644
Rule of 40 score: 27.67751169580342
Financial ratios for CHPT — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 277
Shares outstanding: 25897631
Market cap (USD): 7173643787
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHPT — annual report dated 2023-01-31
Total revenue: 468094000
Gross profit: 85933000
Operating income: -341782000
Net income: -345108000
Capital expenditures: 18563000
Operating cash flow: -267049000
Depreciation & amortization: 25050000
Net tangible assets: 48603000
Owner earnings: -338621000
Return on net tangible assets (%): -696.7080221385511
Buffett classification: The Gruesome
Stock price: 242.8
Shares outstanding: 25897631
Book value: 354992000
P/B ratio: 17.712919746923877
Market cap (USD): 6287944806.8
Debt to equity: 0.8923496867535043
Current ratio: 2.476541837825671
Quick ratio: 2.234820775420629
Interest coverage ratio: -36.22874708501166
COGS to revenue (%): 81.6419351668682
R&D to revenue (%): 41.64911321230351
SG&A to revenue (%): 49.7246279593415
Free cash flow (dilution-adjusted): -378962000
Buyback yield (%): 0
Retained earnings: -1156763000
Inventory turnover: 5.5603230030554345
Receivables turnover: 2.8387914513742327
Capitalized R&D asset: 194957000
ROCI (R&D-adjusted, %): -21.38253289157105
FCF margin (%): -80.95852542438058
Rule of 40 score: -80.95852542438058
Financial ratios for CHPT — annual report dated 2024-01-31
Total revenue: 506639000
Gross profit: 30118000
Operating income: -449951000
Net income: -457609000
Capital expenditures: 19424000
Operating cash flow: -328941000
Depreciation & amortization: 28486000
Net tangible assets: 33371000
Owner earnings: -448547000
Return on net tangible assets (%): -1344.1221419795631
Buffett classification: The Gruesome
Stock price: 38
Shares outstanding: 25897631
Book value: 327676000
P/B ratio: 3.003301975121767
Market cap (USD): 984109978
Debt to equity: 0.9187551117567353
Current ratio: 2.2495115900809624
Quick ratio: 1.6480328817245338
Interest coverage ratio: -27.650156701284335
COGS to revenue (%): 94.05533328464647
R&D to revenue (%): 43.57757693347729
SG&A to revenue (%): 51.17805774920604
Free cash flow (dilution-adjusted): -465692000
Buyback yield (%): 0
Retained earnings: -1614372000
Inventory turnover: 2.399642461476483
Receivables turnover: 4.084184475489525
Capitalized R&D asset: 351402190
ROCI (R&D-adjusted, %): -32.700102008794104
Rosenberg metric: -0.2862939007063096
FCF margin (%): -91.91791393872165
Revenue growth (%): 8.234457181677184
Rule of 40 score: -83.68345675704447
Financial ratios for CHPT — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24
Shares outstanding: 25897631
Market cap (USD): 621543144
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHPT — quarterly report dated 2025-01-31
Total revenue: 101889000
Gross profit: 28700000
Operating income: -54949000
Net income: -58803000
Capital expenditures: 1937000
Operating cash flow: -2682000
Depreciation & amortization: 6987000
Net tangible assets: -136244000
Owner earnings: -53753000
Buffett classification: The Gruesome
Stock price: 19.24
Shares outstanding: 25897631
Book value: 137471000
P/B ratio: 3.6245493263306443
Market cap (USD): 498270420.43999994
Debt to equity: 2.2721810418197292
Current ratio: 1.928788817549856
Quick ratio: 1.216397840311017
Interest coverage ratio: -25.357175819104754
COGS to revenue (%): 71.83209178615945
R&D to revenue (%): 29.85111248515541
SG&A to revenue (%): 52.24705316569993
Free cash flow (dilution-adjusted): -19187000
Buyback yield (%): 0
Retained earnings: -1891438000
Inventory turnover: 0.3497481625904369
Receivables turnover: 1.0623840010009802
Capitalized R&D asset: 30415000
ROCI (R&D-adjusted, %): -5.461551709291312
FCF margin (%): -18.831277174179746
Rule of 40 score: -18.831277174179746
Financial ratios for CHPT — annual report dated 2025-01-31
Total revenue: 417083000
Gross profit: 100681000
Operating income: -252999000
Net income: -277066000
Capital expenditures: 12073000
Operating cash flow: -146947000
Depreciation & amortization: 29192000
Net tangible assets: -136244000
Owner earnings: -259947000
Buffett classification: The Gruesome
Stock price: 19.24
Shares outstanding: 25897631
Book value: 137471000
P/B ratio: 3.6245493263306443
Market cap (USD): 498270420.43999994
Debt to equity: 2.2721810418197292
Current ratio: 1.928788817549856
Quick ratio: 1.216397840311017
Interest coverage ratio: -10.262402141727174
COGS to revenue (%): 75.86068000853547
R&D to revenue (%): 33.87239470321255
SG&A to revenue (%): 50.92607466619354
Free cash flow (dilution-adjusted): -234671000
Buyback yield (%): 0
Retained earnings: -1891438000
Inventory turnover: 1.5119897544704723
Receivables turnover: 4.348872854670198
Capitalized R&D asset: 353535080
ROCI (R&D-adjusted, %): -31.044413829517843
Rosenberg metric: 0.3196063067021166
FCF margin (%): -56.26482019166449
Revenue growth (%): -17.67649154526201
Rule of 40 score: -73.94131173692651
Financial ratios for CHPT — quarterly report dated 2025-04-30
Total revenue: 97640000
Gross profit: 27986000
Operating income: -53840000
Net income: -57121000
Capital expenditures: 1060000
Operating cash flow: -32968000
Depreciation & amortization: 6928000
Net tangible assets: -170543000
Owner earnings: -51253000
Buffett classification: The Gruesome
Stock price: 12.46
Shares outstanding: 25897631
Book value: 118588000
P/B ratio: 2.721055100516073
Market cap (USD): 322684482.26000005
Debt to equity: 2.7169612439707223
Current ratio: 1.820763889345097
Quick ratio: 1.1230020824984726
Interest coverage ratio: -8.36544437538844
COGS to revenue (%): 71.33756657107743
R&D to revenue (%): 34.31995083981975
SG&A to revenue (%): 49.48381810733306
Free cash flow (dilution-adjusted): -51891000
Buyback yield (%): 0
Retained earnings: -1948559000
Inventory turnover: 0.32789462782684015
Receivables turnover: 0.9894107513806556
Capitalized R&D asset: 53888050
ROCI (R&D-adjusted, %): -6.43506262472715
Rosenberg metric: -0.023475258918296892
FCF margin (%): -53.14522736583367
Revenue growth (%): -4.170224459951516
Rule of 40 score: -57.31545182578519
Financial ratios for CHPT — quarterly report dated 2025-07-31
Total revenue: 98590000
Gross profit: 30728000
Operating income: -58977000
Net income: -66179000
Capital expenditures: 1298000
Operating cash flow: -6152000
Depreciation & amortization: 6926000
Net tangible assets: -216570000
Owner earnings: -60551000
Buffett classification: The Gruesome
Stock price: 9.19
Shares outstanding: 25897631
Book value: 70715000
P/B ratio: 3.3656116649932826
Market cap (USD): 237999228.89
Debt to equity: 4.561832708760518
Current ratio: 1.6670729458679843
Quick ratio: 1.0032533588351662
Interest coverage ratio: -8.611038107752957
COGS to revenue (%): 68.83253879703824
R&D to revenue (%): 37.00071001115732
SG&A to revenue (%): 53.98721979916827
Free cash flow (dilution-adjusted): -25666000
Buyback yield (%): 0
Retained earnings: -2014738000
Inventory turnover: 0.3194904122745484
Receivables turnover: 1.02682942070948
Capitalized R&D asset: 68967650
ROCI (R&D-adjusted, %): -9.037784985304272
Rosenberg metric: 0.08182632050134288
FCF margin (%): -26.033066233897962
Revenue growth (%): 0.9729619008603032
Rule of 40 score: -25.06010433303766
Financial ratios for CHPT — quarterly report dated 2025-10-31
Total revenue: 105674000
Gross profit: 32486000
Operating income: -44335000
Net income: -52479000
Capital expenditures: 1062000
Operating cash flow: -22488000
Depreciation & amortization: 6715000
Net tangible assets: -248336000
Owner earnings: -46826000
Buffett classification: The Gruesome
Stock price: 10.8
Shares outstanding: 25897631
Book value: 38383000
P/B ratio: 7.286934705468568
Market cap (USD): 279694414.8
Debt to equity: 8.694786754552796
Current ratio: 1.5855572178582509
Quick ratio: 0.9336474983027104
Interest coverage ratio: -5.499937972956209
COGS to revenue (%): 69.25828491398073
R&D to revenue (%): 32.81318015784394
SG&A to revenue (%): 39.883036508507296
Free cash flow (dilution-adjusted): -39005000
Buyback yield (%): 0
Retained earnings: -2067217000
Inventory turnover: 0.3448864091532404
Receivables turnover: 1.0878413852029525
Capitalized R&D asset: 70174230
ROCI (R&D-adjusted, %): -7.516261964574529
Rosenberg metric: 0.048192110529345654
FCF margin (%): -36.91068758635048
Revenue growth (%): 7.185312912060046
Rule of 40 score: -29.725374674290432
Financial ratios for CHPT — quarterly report dated 2026-01-31
Total revenue: 109320000
Gross profit: 34402000
Operating income: -52986000
Net income: -44418000
Capital expenditures: 745000
Operating cash flow: -1227000
Depreciation & amortization: 6478000
Net tangible assets: -267173000
Owner earnings: -38685000
Buffett classification: The Gruesome
Stock price: 5.99
Shares outstanding: 25897631
Book value: 21299000
P/B ratio: 7.283290750269965
Market cap (USD): 155126809.69
Debt to equity: 12.748391943283723
Current ratio: 1.2045472913608763
Quick ratio: 0.644275215150338
Interest coverage ratio: -21.0763723150358
COGS to revenue (%): 68.53091840468349
R&D to revenue (%): 31.65751920965971
SG&A to revenue (%): 48.28027808269301
Free cash flow (dilution-adjusted): -15132000
Buyback yield (%): 0
Retained earnings: -2111635000
Inventory turnover: 0.34861309521039724
Receivables turnover: 1.269214693725909
Capitalized R&D asset: 69878320
ROCI (R&D-adjusted, %): -11.207087212168517
Rosenberg metric: 0.05525594808940159
FCF margin (%): -13.841931942919869
Revenue growth (%): 3.4502337377216725
Rule of 40 score: -10.391698205198196
Financial ratios for CHPT — annual report dated 2026-01-31
Total revenue: 411224000
Gross profit: 125602000
Operating income: -210138000
Net income: -220197000
Capital expenditures: 4165000
Operating cash flow: -62835000
Depreciation & amortization: 27047000
Net tangible assets: -267173000
Owner earnings: -197315000
Buffett classification: The Gruesome
Stock price: 5.99
Shares outstanding: 25897631
Book value: 21299000
P/B ratio: 7.283290750269965
Market cap (USD): 155126809.69
Debt to equity: 12.748391943283723
Current ratio: 1.2045472913608763
Quick ratio: 0.644275215150338
Interest coverage ratio: -8.80712489522213
COGS to revenue (%): 69.45654922864423
R&D to revenue (%): 33.86767309301014
SG&A to revenue (%): 47.77639437386923
Free cash flow (dilution-adjusted): -131694000
Buyback yield (%): 0
Retained earnings: -2111635000
Inventory turnover: 1.3290740473609024
Receivables turnover: 4.7743463521107135
Capitalized R&D asset: 306784650
ROCI (R&D-adjusted, %): -33.2618805334251
Rosenberg metric: 0.17639938843115605
FCF margin (%): -32.02488181623641
Revenue growth (%): -1.4047563674376562
Rule of 40 score: -33.429638183674065
Financial ratios for CKI.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.125984251968504
Shares outstanding: 12968315
Market cap (USD): 105380323.46456693
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKI.TO — annual report dated 2022-12-31
Total revenue: 44092647.058823526
Net income: 2372058.8235294116
Capital expenditures: 13981617.647058822
Operating cash flow: 2501470.588235294
Depreciation & amortization: 7036764.705882353
Net tangible assets: 158066176.47058824
Owner earnings: -4572794.117647057
Return on net tangible assets (%): -2.892961808624458
Buffett classification: The Gruesome
Stock price: 9.176470588235293
P/E ratio: 50.168806943583384
Shares outstanding: 12968315
Book value: 158066176.4705882
P/B ratio: 0.7528704991394148
Market cap (USD): 119003361.17647058
Debt to equity: 0.7403079499465043
Effective tax rate (%): 39.47467166979362
COGS to revenue (%): 0
SG&A to revenue (%): 71.52219591101624
Free cash flow (dilution-adjusted): -11480147.058823528
Buyback yield (%): 2.332484785872138
Retained earnings: 30572794.117647056
Receivables turnover: 8.617042678545767
Capitalized R&D asset: 0
FCF margin (%): -26.036420638361733
Rule of 40 score: -26.036420638361733
Financial ratios for CKI.TO — annual report dated 2023-12-31
Total revenue: 46949242.42424242
Net income: 2593939.393939394
Capital expenditures: 7017424.242424242
Operating cash flow: 6179545.454545454
Depreciation & amortization: 7711363.636363636
Net tangible assets: 174764393.93939394
Owner earnings: 3287878.787878787
Return on net tangible assets (%): 1.8813207391769868
Buffett classification: The Gruesome
Stock price: 10.818181818181817
P/E ratio: 54.08514550233644
Shares outstanding: 12968315
Book value: 174764393.93939394
P/B ratio: 0.8027584245456002
Market cap (USD): 140293589.54545453
Debt to equity: 0.5469528239317869
Effective tax rate (%): 33.03344416194015
COGS to revenue (%): 0
SG&A to revenue (%): 81.89050070191858
Free cash flow (dilution-adjusted): -837878.7878787878
Buyback yield (%): 0.8002698315474449
Retained earnings: 33500757.575757574
Receivables turnover: 19.673968253968255
Capitalized R&D asset: 0
FCF margin (%): -1.7846481532280185
Revenue growth (%): 6.478620713353732
Rule of 40 score: 4.693972560125713
Financial ratios for CKI.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.748148148148147
Shares outstanding: 12968315
Market cap (USD): 230163575.85185182
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKI.TO — annual report dated 2024-12-31
Total revenue: 74672027.97202797
Net income: 26449650.34965035
Capital expenditures: 9567132.867132867
Operating cash flow: 12505594.405594407
Depreciation & amortization: 7386713.286713287
Net tangible assets: 193665734.2657343
Owner earnings: 24269230.769230776
Return on net tangible assets (%): 12.531504791617017
Buffett classification: The Gruesome
Stock price: 16.503496503496507
P/E ratio: 8.091696428099306
Shares outstanding: 12968315
Book value: 193665734.2657343
P/B ratio: 1.1051131067154858
Market cap (USD): 214022541.2587413
Debt to equity: 0.6688548504741065
Effective tax rate (%): 18.354703622156023
COGS to revenue (%): 0
SG&A to revenue (%): 43.48151824762832
Free cash flow (dilution-adjusted): 2938461.5384615385
Buyback yield (%): 0.04084270138018335
Retained earnings: 57318181.81818182
Receivables turnover: 30.053757388122715
Capitalized R&D asset: 0
FCF margin (%): 3.9351570035867804
Revenue growth (%): 59.048419348872784
Rule of 40 score: 62.983576352459565
Financial ratios for CKI.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.503496503496507
Shares outstanding: 12968315
Market cap (USD): 214022541.2587413
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKI.TO — quarterly report dated 2025-03-31
Total revenue: 10464335.664335664
Net income: -1649650.3496503497
Capital expenditures: 1541958.041958042
Operating cash flow: -1094405.5944055945
Depreciation & amortization: 2010489.5104895106
Net tangible assets: 195008391.6083916
Owner earnings: -1181118.881118881
Return on net tangible assets (%): -0.6056759257267035
Buffett classification: The Gruesome
Stock price: 15.853146853146855
Shares outstanding: 12968315
Book value: 195008391.6083916
P/B ratio: 1.0542551550587747
Market cap (USD): 205588602.13286716
Debt to equity: 0.7553664536580817
COGS to revenue (%): 0
SG&A to revenue (%): 80.08553862603583
Free cash flow (dilution-adjusted): -2636363.6363636367
Buyback yield (%): 0.3731397845864466
Retained earnings: 55102797.202797204
Receivables turnover: 1.6775784753363228
Capitalized R&D asset: 0
FCF margin (%): -25.19379844961241
Rule of 40 score: -25.19379844961241
Financial ratios for CKI.TO — quarterly report dated 2025-06-30
Total revenue: 11962043.795620438
Net income: -61313.86861313868
Capital expenditures: 2662773.722627737
Operating cash flow: -156934.30656934305
Depreciation & amortization: 2132116.7883211677
Net tangible assets: 198399999.99999997
Owner earnings: -591970.8029197082
Return on net tangible assets (%): -0.2983723805038852
Buffett classification: The Gruesome
Stock price: 17.708029197080293
Shares outstanding: 12968315
Book value: 198399999.99999997
P/B ratio: 1.1574763137950321
Market cap (USD): 229643300.65693432
Debt to equity: 0.8982553861549329
Effective tax rate (%): 167.74193548387095
COGS to revenue (%): 0
SG&A to revenue (%): 75.73224310471076
Free cash flow (dilution-adjusted): -2819708.02919708
Buyback yield (%): 1.792052481122104
Retained earnings: 54427007.29927007
Receivables turnover: 1.4044048333190506
Capitalized R&D asset: 0
FCF margin (%): -23.572125945814008
Revenue growth (%): 14.312500853630219
Rule of 40 score: -9.25962509218379
Financial ratios for CKI.TO — quarterly report dated 2025-09-30
Total revenue: 26111510.79136691
Net income: 11384172.661870504
Capital expenditures: 2572661.8705035974
Operating cash flow: 9137410.071942447
Depreciation & amortization: 2162589.928057554
Net tangible assets: 208432374.10071945
Owner earnings: 10974100.71942446
Return on net tangible assets (%): 5.265065355980408
Buffett classification: The Gruesome
Stock price: 20.287769784172664
P/E ratio: 27.198647764332385
Shares outstanding: 12968315
Book value: 208432374.10071945
P/B ratio: 1.2622712299073937
Market cap (USD): 263098189.20863312
Debt to equity: 0.8990718656914755
Effective tax rate (%): 24.944267893563534
COGS to revenue (%): 0
SG&A to revenue (%): 30.82242733158837
Free cash flow (dilution-adjusted): 6550359.712230217
Buyback yield (%): 0
Retained earnings: 65028057.55395684
Receivables turnover: 4.666966696669667
Capitalized R&D asset: 0
FCF margin (%): 25.086100013776004
Revenue growth (%): 118.28636675721667
Rule of 40 score: 143.37246677099267
Financial ratios for CKI.TO — quarterly report dated 2025-12-31
Total revenue: 12076642.335766422
Net income: -265693.4306569343
Capital expenditures: 1797080.2919708027
Operating cash flow: 3783211.6788321165
Depreciation & amortization: 2526277.3722627736
Net tangible assets: 209059854.01459852
Owner earnings: 463503.6496350367
Buffett classification: The Gruesome
Stock price: 15.27737226277372
P/E ratio: 21.059947882430624
Shares outstanding: 12968315
Book value: 209059854.01459852
P/B ratio: 0.9476796815426728
Market cap (USD): 198121775.8759124
Debt to equity: 0.9963164951189196
COGS to revenue (%): 0
SG&A to revenue (%): 76.59715926261711
Free cash flow (dilution-adjusted): 1977372.2627737224
Buyback yield (%): 0.5143190836468108
Retained earnings: 64962773.72262773
Receivables turnover: 5.691434468524252
Capitalized R&D asset: 0
FCF margin (%): 16.373526745240255
Revenue growth (%): -53.749737300687904
Rule of 40 score: -37.37621055544765
Financial ratios for CKI.TO — annual report dated 2025-12-31
Total revenue: 61443065.693430655
Net income: 9501459.854014598
Capital expenditures: 8679562.04379562
Operating cash flow: 11754744.525547445
Depreciation & amortization: 8951094.890510948
Net tangible assets: 209059854.01459852
Owner earnings: 9772992.700729925
Return on net tangible assets (%): 4.674734298842227
Buffett classification: The Gruesome
Stock price: 15.27737226277372
P/E ratio: 20.851719516785742
Shares outstanding: 12968315
Book value: 209059854.01459852
P/B ratio: 0.9476796815426728
Market cap (USD): 198121775.8759124
Debt to equity: 0.9963164951189196
Effective tax rate (%): 25.17675461286429
COGS to revenue (%): 0
SG&A to revenue (%): 57.32563526854128
Free cash flow (dilution-adjusted): 3051824.8175182478
Buyback yield (%): 2.995650765854025
Retained earnings: 64962773.72262773
Receivables turnover: 28.95665634674923
Capitalized R&D asset: 0
FCF margin (%): 4.966914953015669
Revenue growth (%): -17.716088122787916
Rule of 40 score: -12.749173169772247
Financial ratios for CMU.V — annual report dated 2022-01-31
Total revenue: 331757.03125
Gross profit: 156199.21875
Operating income: -40680.46875
Net income: 281402.34375
Capital expenditures: 0
Operating cash flow: -32268.75
Depreciation & amortization: 871.875
Net tangible assets: 1360900.78125
Owner earnings: 282274.21875
Return on net tangible assets (%): 20.741719208267963
Buffett classification: The Gruesome
Stock price: 2.265625
P/E ratio: 38.60167742472827
Shares outstanding: 4794528
Book value: 1360900.78125
P/B ratio: 7.981920981794572
Market cap (USD): 10862602.5
Debt to equity: 0.4352746601085104
Current ratio: 3.9133653571855818
Quick ratio: 3.9133653571855818
Interest coverage ratio: -1.7987149815192234
COGS to revenue (%): 52.91758605342295
R&D to revenue (%): 0
SG&A to revenue (%): 41.9515882528865
Free cash flow (dilution-adjusted): -32268.75
Buyback yield (%): 0
Retained earnings: -2059369.53125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1390271084745662
FCF margin (%): -9.726621280163146
Rule of 40 score: -9.726621280163146
Financial ratios for CMU.V — annual report dated 2023-01-31
Total revenue: 454850
Gross profit: 295745.5223880597
Operating income: -8468.65671641791
Net income: -90405.97014925373
Capital expenditures: 0
Operating cash flow: -38875.37313432836
Depreciation & amortization: 791.044776119403
Net tangible assets: 1209558.9552238805
Owner earnings: -89614.92537313432
Return on net tangible assets (%): -7.408892719623348
Buffett classification: The Gruesome
Stock price: 3.171641791044776
Shares outstanding: 4794528
Book value: 1209558.9552238807
P/B ratio: 12.571958818096393
Market cap (USD): 15206525.373134328
Debt to equity: 0.4413894542786965
Current ratio: 0.8576084903579834
Quick ratio: 0.8576084903579834
Interest coverage ratio: -0.3787590534361337
COGS to revenue (%): 34.97954877694631
R&D to revenue (%): 18.07484507767855
SG&A to revenue (%): 40.49309350794669
Free cash flow (dilution-adjusted): -38875.37313432836
Buyback yield (%): 0
Retained earnings: -2057564.9253731342
Capitalized R&D asset: 82213.43283582089
ROCI (R&D-adjusted, %): 3.5873423937376323
FCF margin (%): -8.546855696235761
Revenue growth (%): 37.10334888343078
Rule of 40 score: 28.556493187195024
Financial ratios for CMU.V — annual report dated 2024-01-31
Total revenue: 263360.447761194
Gross profit: 133167.91044776118
Operating income: -686526.8656716418
Net income: 6081921.641791045
Capital expenditures: 13432.835820895521
Operating cash flow: -530584.3283582089
Depreciation & amortization: 373.13432835820896
Net tangible assets: 7486914.925373134
Owner earnings: 6068861.940298507
Return on net tangible assets (%): 81.05958196120476
Buffett classification: The Gruesome
Stock price: 3.059701492537313
P/E ratio: 2.412037731103006
Shares outstanding: 4794528
Book value: 7486914.925373134
P/B ratio: 1.959395107842877
Market cap (USD): 14669824.477611938
Debt to equity: 0
Current ratio: 6.973047212524791
Quick ratio: 6.973047212524791
Effective tax rate (%): 11.50951027576678
Interest coverage ratio: -54.03500734214391
COGS to revenue (%): 49.43511389815332
R&D to revenue (%): 151.79128542404004
SG&A to revenue (%): 148.38950079766963
Free cash flow (dilution-adjusted): -739451.4925373134
Buyback yield (%): 0
Retained earnings: 4024356.71641791
Receivables turnover: 4.705436072480967
Capitalized R&D asset: 454841.20895522385
ROCI (R&D-adjusted, %): -5.633840463984549
Rosenberg metric: -1.977506671749905
FCF margin (%): -280.77545387826115
Revenue growth (%): -42.09949483100054
Rule of 40 score: -322.8749487092617
Financial ratios for CMU.V — quarterly report dated 2024-10-31
Total revenue: 0
Gross profit: -30812.94964028777
Operating income: -76903.59712230216
Net income: -21256.11510791367
Capital expenditures: 0
Operating cash flow: -524735.9712230216
Depreciation & amortization: 485.6115107913669
Net tangible assets: 7071063.309352518
Owner earnings: -20770.5035971223
Return on net tangible assets (%): -0.2937394658827374
Buffett classification: The Gruesome
Stock price: 3.0575539568345325
Shares outstanding: 4794528
Book value: 7071063.309352518
P/B ratio: 2.073171659793313
Market cap (USD): 14659528.057553958
Debt to equity: 0
Current ratio: 221.11383705052344
Quick ratio: 221.11383705052344
Free cash flow (dilution-adjusted): -531220.8633093525
Buyback yield (%): 0
Retained earnings: 3709650.3597122305
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0875817929756884
Rule of 40 score: 0
Financial ratios for CMU.V — annual report dated 2025-01-31
Total revenue: 0
Gross profit: -121711.03448275862
Operating income: -432591.7241379311
Net income: -275888.9655172414
Capital expenditures: 0
Operating cash flow: -1028713.103448276
Depreciation & amortization: 3826.896551724138
Net tangible assets: 6671708.9655172415
Owner earnings: -272062.0689655173
Return on net tangible assets (%): -4.077846776165917
Buffett classification: The Gruesome
Stock price: 2.793103448275862
Shares outstanding: 4794528
Book value: 6671708.9655172415
P/B ratio: 2.007223750147044
Market cap (USD): 13391612.689655172
Debt to equity: 0.004451219550013448
Current ratio: 20.315934202051235
Quick ratio: 20.315934202051235
Interest coverage ratio: -30.26284556375742
Free cash flow (dilution-adjusted): -1057368.9655172415
Buyback yield (%): 0
Retained earnings: 3443171.724137931
Receivables turnover: 0
Capitalized R&D asset: 354729.8121461657
ROCI (R&D-adjusted, %): -7.850974711915926
Rosenberg metric: -0.63758276683461
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CMU.V — quarterly report dated 2025-01-31
Total revenue: 2233.1034482758623
Gross profit: -42448.965517241384
Operating income: -134191.72413793104
Net income: -112975.86206896552
Capital expenditures: 0
Operating cash flow: 200449.6551724138
Depreciation & amortization: 2430.344827586207
Net tangible assets: 6671708.9655172415
Owner earnings: -110545.51724137932
Return on net tangible assets (%): -1.6569295485269868
Buffett classification: The Gruesome
Stock price: 2.793103448275862
Shares outstanding: 4794528
Book value: 6671708.9655172415
P/B ratio: 2.007223750147044
Market cap (USD): 13391612.689655172
Debt to equity: 0.004451219550013448
Current ratio: 20.315934202051235
Quick ratio: 20.315934202051235
Interest coverage ratio: -230.8161328588375
COGS to revenue (%): 2000.895614576899
R&D to revenue (%): 0
SG&A to revenue (%): 3974.953675108091
Free cash flow (dilution-adjusted): 194232.41379310345
Buyback yield (%): 0
Retained earnings: 3443171.724137931
Receivables turnover: 0.010415761962203458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.004603279081701
FCF margin (%): 8697.869054972205
Rule of 40 score: 8697.869054972205
Financial ratios for CMU.V — quarterly report dated 2025-04-30
Total revenue: 0
Gross profit: -23823.913043478264
Operating income: -181440.57971014493
Net income: -146750
Capital expenditures: 0
Operating cash flow: -12872.463768115944
Depreciation & amortization: 2553.6231884057975
Net tangible assets: 6969013.768115942
Owner earnings: -144196.3768115942
Return on net tangible assets (%): -2.069107360230935
Buffett classification: The Gruesome
Stock price: 2.8985507246376816
Shares outstanding: 4794528
Book value: 6969013.768115942
P/B ratio: 1.9941390663162266
Market cap (USD): 13897182.608695654
Debt to equity: 0.004211707746890766
Current ratio: 35.451336164774865
Quick ratio: 35.451336164774865
Interest coverage ratio: -364.9970845481049
Free cash flow (dilution-adjusted): -118507.24637681161
Buyback yield (%): 0
Retained earnings: 3471075.362318841
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.594742968754129
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CMU.V — quarterly report dated 2025-07-31
Gross profit: -49991.30434782609
Operating income: -155718.84057971014
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.0434782608695654
Shares outstanding: 4794528
Market cap (USD): 14592041.739130436
Interest coverage ratio: -25.20136038466049
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMU.V — quarterly report dated 2025-10-31
Total revenue: 0
Gross profit: -32802.857142857145
Operating income: -104844.28571428572
Net income: -96313.57142857143
Capital expenditures: 0
Operating cash flow: -654350
Depreciation & amortization: 2517.1428571428573
Net tangible assets: 6602848.571428572
Owner earnings: -93796.42857142858
Return on net tangible assets (%): -1.4205448990197738
Buffett classification: The Gruesome
Stock price: 3.2142857142857144
Shares outstanding: 4794528
Book value: 6602848.571428572
P/B ratio: 2.33399004845095
Market cap (USD): 15410982.857142858
Debt to equity: 0.003814911918968307
Current ratio: 0.8267685735213471
Quick ratio: 0.8267685735213471
Interest coverage ratio: -243.82392026578074
Free cash flow (dilution-adjusted): -654350
Buyback yield (%): 0
Retained earnings: 3154880.7142857146
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.582287759869814
Rule of 40 score: 0